Evidence map›Paper›PMID 17982126›Full record

ArticleThe American journal of pathology2007

The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney.

Philipp Lechler, Xiaoqing Wu, Wanja Bernhardt, Valentina Campean, Susanne Gastiger, Thomas Hackenbeck, Bernd Klanke, Alexander Weidemann, Christina Warnecke, Kerstin Amann and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Survivin mediates renal proximal tubule recovery from AKI.Journal of the American Society of Nephrology : JASN · 2013
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Philipp LechlerInterdisciplinary Center for Clinical Research, Friedrich-Alexander University Erlangen-Nuremberg, Nuremberg, Germany.
Xiaoqing Wu
Wanja Bernhardt
Valentina Campean
Susanne Gastiger
Thomas Hackenbeck
Bernd Klanke
Alexander Weidemann
Christina Warnecke
Kerstin Amann
Dirk Engehausen
Carsten Willam
Kai-Uwe Eckardt
Franz Rödel
Michael Sean Wiesener
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEGoethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inhibitor of apoptosis protein survivin is of critical importance for regulation of cellular division and survival. Published data point to a restricted function of survivin in embryonic development and cancer; thus survivin has been broadly proposed as an ideal molecular target for specific anti-cancer therapy. In contrast to this paradigm, we report here broad expression of survivin in adult differentiated tissues, as demonstrated at the mRNA and protein levels. Focusing on the kidney, survivin is strongly expressed in proximal tubuli, particularly at the apical membrane, which can be verified in rat, mouse, and human kidneys. In the latter, survivin expression seems to be even stronger in proximal tubuli than in adjacent cancerous tissue. Primary and immortalized human renal tubular cells also showed high levels of survivin protein expression, and RNA interference resulted in a partial G(2)/M arrest of the cell cycle and increased rate of apoptosis. In conclusion, survivin may be of importance for renal pathophysiology and pathology. The predominant apical expression of survivin may indicate a further, yet unknown, function. Interventional strategies to inhibit survivin's function in malignancy need to be carefully (re)evaluated for renal side effects, as well as for other possible organ dysfunctions.

Indexed as

AnimalsCells, CulturedHumansInhibitor of Apoptosis ProteinsKidneyKidney NeoplasmsMaleMiceMice, Inbred C57BLMicrotubule-Associated ProteinsNeoplasm ProteinsRatsRats, Sprague-DawleyRepressor ProteinsSurvivinBIRC5 protein, humanBirc5 protein, mouseBirc5 protein, ratInhibitor of Apoptosis ProteinsMicrotubule-Associated ProteinsNeoplasm ProteinsRepressor ProteinsSurvivin

Identifiers

PMID17982126
PMCPMC2043510
OpenAlexW159878913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.